2026-07-22T15:01:22-05:00 2025-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2025-01-01 522275294 SARCOMA FOUNDATION OF AMERICA SARC 3012538687 7700 WISCONSIN AVENUE 310 BETHESDA MD 20814 BRANDI FELSER CEO 3012538687 2026-07-20 1 MARK C THOMAS P00362982 3019860600 2026-07-21 2025 2025-03-06 01:10:19Z X BRANDI FELSER 7700 WISCONSIN AVENUE 310 BETHESDA MD 20814 6347762 0 X WWW.CURESARCOMA.ORG X 2000 MD WE ADVOCATE FOR SARCOMA PATIENTS BY FUNDING RESEARCH, INCREASING AWARENESS, AND PROVIDING PATIENT EDUCATION. 10 10 25 107 0 0 3185724 2825668 70000 0 451436 576875 -159258 -40335 3547902 3362208 934210 1239448 0 0 1764175 1986877 0 0 422345 872237 1076740 3570622 4303065 -22720 -940857 11423128 10848548 398808 430677 11024320 10417871 X THE MISSION OF THE ORGANIZATION IS TO ADVOCATE FOR SARCOMA PATIENTS BY FUNDING RESEARCH AND BY INCREASING AWARENESS ABOUT THE DISEASE. THE ORGANIZATION RAISES MONEY TO PRIVATELY FUND GRANTS FOR SARCOMA RESEARCHERS AND CONDUCTS EDUCATION AND ADVOCACY EFFORTS ON BEHALF OF SARCOMA PATIENTS. 0 0 3244504 1239448 3201 THE SARCOMA FOUNDATION OF AMERICA (SFA) COORDINATES A NATIONAL RESEARCH GRANT PROGRAM THAT FUNDS TRANSLATIONAL SCIENCE SARCOMA RESEARCH. IN ACCORDANCE WITH THE MISSION OF THE SFA, RESEARCH INVOLVING THE DEVELOPMENT OF NOVEL AGENTS AGAINST SARCOMA, OR RESEARCH THAT COULD POTENTIALLY LEAD TO THE DEVELOPMENT OF NOVEL AGENTS AGAINST SARCOMA, IS SUPPORTED THROUGH THIS FUNDING. THE SFA ENGAGES IN PATIENT EDUCATION PROGRAMS ON THE LATEST DEVELOPMENTS IN SARCOMA RESEARCH AND TREATMENTS. THESE EDUCATION INITIATIVES ARE DESIGNED TO FURTHER STRENGTHEN AND DEEPEN PATIENTS' ABILITY TO PARTICIPATE IN THEIR CARE AND RESEARCH PROJECTS. SFA ALSO CONDUCTS ADVOCACY ACTIVITIES ON BEHALF OF THE SARCOMA COMMUNITY TO ENSURE ADEQUATE FEDERAL CANCER RESEARCH FUNDING LEVELS AND POLICIES THAT POSITIVELY IMPACT SARCOMA PATIENTS. 3244504 1 1 0 1 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 39 0 1 25 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 10 10 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 CA CT FL GA IL KY MA MD MI MN NC NJ NY OR PA SC VA TN WV WI MS AR HI KS NH NM AK CO ME OH OK WA X X THE ORGANIZATION 3012538687 7700 WISCONSIN AVENUE 310 BETHESDA MD 20814 MARK THORNTON PRESIDENT 3.00 X X 0 0 0 JOHN BROOKS VICE PRESIDENT 1.00 X X 0 0 0 PATRICIA THORNTON TREASURER 3.00 X X 0 0 0 JENNIFER GOODWIN SECRETARY 1.00 X X 0 0 0 CHRIS CONNERY DIRECTOR 1.00 X 0 0 0 MICHAEL LEWIS DIRECTOR 1.00 X 0 0 0 JUSTIN GREEN DIRECTOR 1.00 X 0 0 0 BRUCE MARCH DIRECTOR 1.00 X 0 0 0 JENNIFER NELLANY DIRECTOR 1.00 X 0 0 0 MICHAEL BARRON DIRECTOR 1.00 X 0 0 0 BRANDI FELSER CEO 40.00 X 239104 0 22764 DEAN FROHLICH DIRECTOR OF SCIENTIFIC AFFAIRS 40.00 X 147273 0 18826 ANNIE BLAKE NATIONAL DIRECTOR, RTCS 40.00 X 109476 0 18775 CLAIRE WANG FINANCE DIRECTOR 40.00 X 131616 0 17550 CHERYL MAYES DIRECTOR OF OPERATIONS 40.00 X 107976 0 20584 735445 0 98499 5 0 1 0 ROSE GROUP PARK AVENUE LLC 583 PARK AVENUE NEW YORK NY 10065 EVENT SPACE RENTAL 131798 1 8253 1171492 96598 1549325 26810 2825668 298353 298353 2653161 2374639 278522 278522 278522 567379 1171492 610915 -43536 -43536 MISCELLANEOUS REVENUE 900099 3201 3201 3201 3362208 3201 0 533339 1067408 1067408 24440 24440 147600 147600 261868 184001 50737 27130 1403011 985823 271834 145354 55498 38996 10752 5750 137488 96606 26638 14244 129012 90650 24996 13366 27326 11123 16203 34719 34719 46971 46971 264679 144145 67570 52964 43407 30500 8410 4497 142440 68705 26837 46898 85490 60069 16564 8857 83326 58549 16144 8633 6753 6753 243236 154513 88723 32688 22968 6333 3387 11585 8140 2245 1200 SPONSORSHIP 21030 21030 DUES AND SUBSCRIPTIONS 15800 15800 REGISTRATION FEES 12956 9104 2510 1342 MISCELLANEOUS EXPENSES 4334 4334 4303065 3244504 636216 422345 X 18821 14819 1603 2399 1264566 407980 446566 1118683 124126 151394 60725 74931 242835 194391 74983 48444 9343301 9001223 108861 45893 11423128 10848548 233287 222441 57035 127600 17475 108486 63161 398808 430677 X 8954255 8601034 2070065 1816837 11024320 10417871 11423128 10848548 -940857 334408 0 X X 0 1 X 1 0 X 3432529 3559687 3689910 3185724 2825668 16693518 270951 346957 398834 508667 567379 2092788 3703480 3906644 4088744 3694391 3393047 18786306 0 0 0 18786306 97262 125558 207691 291686 298353 1020550 97262 125558 207691 291686 298353 1020550 664 641 184 29727 3201 34417 3801406 4032843 4296619 4015804 3694601 19841273 0.94680 0.95190 0.05140 0.04640 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS REVENUE - 2021 AMOUNT: $ 664. 2022 AMOUNT: $ 641. 2023 AMOUNT: $ 184. 2024 AMOUNT: $ 29,727. 2025 AMOUNT: $ 3,201. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 4097 4097 4298968 4303065 365153 91288 0 0 284507 311122 328531 365153 1289313 1933970 861 346 3680 4097 8984 71127 77781 82133 91288 322329 483494 433767 25000 64486 523253 1056802 25000 76434 724469 433767 905220 25000 126582 1056802 892197 140000 -126977 905220 705148 90000 97049 892197 0.62470 0.37530 0 0 78190 65749 12441 83337 56628 26709 81308 72014 9294 48444 OPERATING LEASE LIABILITY 22303 REFUNDABLE ADVANCES 40858 63161 X 3708907 334408 15726 43536 393670 3315237 46971 46971 3362208 4315356 15726 43536 59262 4256094 46971 46971 4303065 PART X, LINE 2: TAX STATUS THE ORGANIZATION IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE EXCEPT ON NET INCOME DERIVED FROM UNRELATED BUSINESS ACTIVITIES AND IS NOT CONSIDERED A "PRIVATE FOUNDATION" BY THE INTERNAL REVENUE SERVICE. THE ORGANIZATION REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THE ORGANIZATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. THE ORGANIZATION'S FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, IS SUBJECT TO EXAMINATION BY THE TAXING AUTHORITIES GENERALLY FOR THREE YEARS AFTER FILING. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENTS EXPENSE 43,536. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENTS EXPENSE 43,536. 0 NORTH AMERICA 0 0 PROGRAM SERVICES CANCER RESEARCH 75000 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS CANCER RESEARCH 72600 0 0 0 0 0 0 147600 0 147600 NORTH AMERICA GRANT - GLADDY -- RICHARD AND VALERIE ARONSOHN MEMORIAL RESEARCH AWARD (1) 75000 0 EUROPE (INCLUDING ICELAND & GREENLAND) GRANT - PASQUALI -- TECHNOBLADE MEMORIAL RESEARCH AWARD 72600 0 0 2 0 0 0 0 0 0 PART I, LINE 2: GRANTEES ARE REQUIRED TO PROVIDE FINAL SCIENTIFIC REPORT AND FINAL FINANCIAL REPORT AFTER THE CONCLUSION OF THE ONE-YEAR GRANT PERIOD. GALA 366378 158029 208349 6637 27200 186225 OTHER EVENTS 1372493 1013463 359030 16880 25797 18314 19592 310270 1738871 1171492 567379 23517 25797 18314 46792 496495 610915 -43536 1 THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULDEVARD HOUSTON TX 77030 746001118 501C (3) 51419 0 GRANT - WANTONG YAO; SARCOMA FOUNDATION OF AMERICA RESEARCH AWARD CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501C (3) 35000 0 GRANT - POBBATI -- EHE FOUNDATION AWARD NO. 1518627 SPONSOR: SARCOMA FOUNDATION OF AMERICA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA DAVIS OFFICE OF RESEARCH ONE SHIELDS AVE MRAK HALL 4TH FLOOR DAVIS CA 95616 946036494 501C (3) 75000 0 GRANT - CARR-ASCHER -- RICHARD AND VALERIE ARONSOHN MEMORIAL RESEARCH AWARD (1) CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501C (3) 75000 0 GRANT - T CHAN -- CHRIS LANGBEIN MEMORIAL RESEARCH AWARD PROVIDENCE PORTLAND MEDICAL FOUNDATION 4805 NE GLISAN ST SUITE 1G14 PORTLAND OR 97213 931231494 501C (3) 75000 0 GRANT - J HUANG -- MARCIA BRODSKY MEMORIAL RESEARCH AWARD NEW YORK MEDICAL COLLEGE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595 131099420 501C (3) 74250 0 GRANT - M CAIRO -- JOHN O'BRIEN MEMORIAL RESEARCH AWARD (1) UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL 55 LAKE AVENUE NORTH WORCESTER MA 01655 043167352 501C (3) 149999 0 MATTHEW HEMMING -- LAST MILE RESEARCH AWARD GEORGETOWN UNIVERSITY 37TH O STREETS NW BOX 571173 WASHINGTON DC 20057 530196603 501C (3) 75000 0 GRANT - J TORETSKY -- SCOTT LIVELY MEMORIAL RESEARCH AWARD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES BOX 957089 1125 MURPHY 405 HILGARD AVE LOS ANGELES CA 90095 956006143 501C (3) 75000 0 GRANT - T MCCAW -- JOHN O'BRIEN MEMORIAL RESEARCH AWARD (2) THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULDEVARD HOUSTON TX 77030 746001118 501C (3) 74745 0 GRANT-DAHN TRUONG -- 2024 GIVING TUESDAY DONORS RESEARCH AWARD UNIVERSITY OF PITTSBURGH 4200 FIFTH AVENUE PITTSBURGH PA 15260 250965591 501C (3) 75000 0 GRANT - E. BRAVERMAN -- LOUISE DUFFY MEMORIAL RESEARCH AWARD MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131924235 501C (3) 75000 0 GRANT-GEORGE LI -- JAY VERNON JACKSON MEMORIAL RESEARCH AWARD MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131924235 501C (3) 75000 0 GRANT - F VANOLI -- TODD BARON MEMORIAL RESEARCH AWARD UM BOARD OF REGENTS (UNIV MICHIGAN SPORE) 1500 E MEDICAL CENTER DR ROGEL CANCER CENTER 4316 ANN ARBOR MI 48109 386006309 501C (3) 25000 0 YEAR 3 SPORE -- GRANT NIH - GENETICS, GENOMICS OF LEIOMYOSARCOMA - DIAGNOSIS, TREATMENT - YEAR 3 CLEVELAND CLINIC PHILANTHROPY INSTITUTE PO BOX 931517 CLEVELAND OH 44193 340714585 501C (3) 56995 0 2024 GRANT -- 1/2 PROCEEDS RTCS CLEVELAND 15 JORDAN'S DREAM FUND 1 5000 JORDAN'S DREAM FUND 1 5000 JORDAN'S DREAM FUND 1 3600 JORDAN'S DREAM FUND 1 5000 JORDAN'S DREAM FUND 1 5000 JORDAN'S DREAM FUND 1 840 PART I, LINE 2: APPLICANTS FOR SFA GRANTS MUST SUBMIT AN APPLICATION OUTLINING THEIR PROPOSED RESEARCH PROJECT ALONG WITH A DETAILED BUDGET THAT DEMONSTRATES HOW THE AWARD MONEY IS TO BE USED. APPLICANTS ARE MADE AWARE THAT A REQUIREMENT OF THE ACCEPTANCE OF GRANT MONEY IS THAT A FINAL REPORT WILL BE SUBMITTED TO SFA AT THE END OF THE ONE-YEAR GRANT PERIOD. THE FINAL REPORT AND BUDGET IS DUE TO SFA BY JULY 31ST OF THE YEAR AFTER THE AWARD IS MADE. FINAL REPORTS ARE TO CONTAIN INFORMATION ON HOW THE RESEARCH PROGRESSES AND IT MUST BE SIGNED BY BOTH THE PRIMARY INVESTIGATOR AS WELL AS THEIR DEPARTMENT CHAIR. X X X X 0 0 0 0 0 0 0 0 0 BRANDI FELSER CEO 222104 0 17000 0 0 0 9644 0 13120 0 261868 0 0 0 DEAN FROHLICH DIRECTOR OF SCIENTIFIC AFFAIRS 147273 0 0 0 0 0 6279 0 12547 0 166099 0 0 0 X 2 26810 FAIR MARKET VALUE 0 0 0 PART I, COLUMN (B): REPRESENTS THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION A, LINE 2 PATRICIA THORNTON, TREASURER, AND MARK THORNTON, PRESIDENT, HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE DIRECTOR, CEO, AND TREASURER REVIEWED THE FORM 990 BASED ON THE FINANCIAL RECORDS, POLICIES, AND PROGRAMS OF THE ORGANIZATION PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C AT LEAST ONCE A YEAR, OFFICERS AND DIRECTORS ACTING ON BEHALF OF THE SARCOMA FOUNDATION OF AMERICA, SHALL EXECUTE AND SUBMIT A STATEMENT TO THE PRESIDENT DISCLOSING ALL MATERIAL FACTS CONCERNING ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST OR CONFIRMING THAT THERE ARE NO SUCH CONFLICTS TO BE DISCLOSED. FORM 990, PART VI, SECTION B, LINE 15A THE BOARD OF DIRECTORS HAS AN APPOINTED A COMPENSATION COMMITTEE THAT ON AN ANNUAL BASIS, REVIEWS AND RECOMMENDS TO THE BOARD THE SALARY OF THE CEO USING CURRENT ECONOMIC DATA. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS ARE AVAILABLE ON THE WEBSITE AS WELL AS UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS NOT CHANGED EITHER ITS OVERSIGHT PROCESS OR SELECTION PROCESS DURING THE TAX YEAR.